New Cocrystals of Antipsychotic Drug Aripiprazole: Decreasing the Dissolution through Cocrystallization

Molecules. 2021 Apr 21;26(9):2414. doi: 10.3390/molecules26092414.

Abstract

Cocrystallization is an important route to tuning the solubility in drugs development, including improving and reducing. Five cocrystals of aripiprazole (ARI) with resveratrol (RSV) and kaempferol (KAE), ARI-RSV, ARI2-RSV1·MeOH, ARI-KAE, ARI-KAE·EtOH, ARI-KAE·IPA, were synthesized and characterized. The single crystal of ARI2-RSV1·MeOH, ARI-KAE·EtOH, and ARI-KAE·IPA were analyzed by single crystal X-ray diffraction (SCXRD). The SCXRD showed multiple intermolecular interactions between API and the coformers, including hydrogen bond, halogen bond, and π-π interactions. Dissolution rate of the two nonsolvate ARI-RSV and ARI-KAE cocrystals were investigated through powder dissolution experiment in pH = 4.0 acetate buffer and pH = 6.8 phosphate buffer. The result showed that RSV could reduce the dissolution rate and solubility of ARI in both medium through cocrystallization. However, KAE improved the dissolution rate and solubility of ARI in pH = 4.0 medium, on the contrary, the two solubility indicators of ARI were both reduced for ARI-KAE cocrystal.

Keywords: aripiprazole; cocrystal; dissolution rate; kaempferol; resveratrol.

MeSH terms

  • Antipsychotic Agents / chemistry*
  • Antipsychotic Agents / pharmacology*
  • Aripiprazole / chemistry*
  • Aripiprazole / pharmacology*
  • Crystallization
  • Crystallography, X-Ray
  • Hydrogen Bonding
  • Models, Molecular*
  • Molecular Conformation
  • Molecular Structure
  • Solubility
  • Spectroscopy, Fourier Transform Infrared
  • Thermogravimetry
  • X-Ray Diffraction

Substances

  • Antipsychotic Agents
  • Aripiprazole